Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy. - Lutz R; Grünschläger F; Simon M; Awwad MHS; Bauer M; Yousefian S; Beumer N; Jopp-Saile L; Sedlmeier A; Solé-Boldo L; Avanesyan B; Vonficht D; et al. (Nature communications, 2024)